ROCKVILLE, Md. — The American Society of Human Genetics (ASHG), the world’s preeminent professional membership organization for human genetics and genomics, has unveiled the seven recipients of its prestigious 2026 Professional Awards. The honorees, representing a cross-section of global leaders in research, advocacy, education, and clinical mentorship, will be formally celebrated during the ASHG 2026 Annual Meeting in Montréal, scheduled for October 20-24.
The awards serve as a high-water mark for the field, recognizing individuals whose life’s work has transitioned genetics from a theoretical discipline to a cornerstone of modern clinical care. From the pioneering identification of disease-linked genes to the development of the "Humane Genetics Curriculum" designed to combat misinformation, these awardees represent the multifaceted evolution of human genetics.
The 2026 Honorees: A Legacy of Innovation
The ASHG selection committee has chosen a group whose impact spans decades of scientific inquiry and societal transformation.
ASHG Lifetime Achievement Award: Dr. Yusuke Nakamura
Dr. Nakamura, currently the President of the National Institutes of Biomedical Innovation, Health and Nutrition in Japan, receives the Society’s highest honor. His career is characterized by an uncanny ability to anticipate the needs of the genomic era. In the 1980s, his development of Variable Number Tandem Repeat (VNTR) markers served as a fundamental catalyst for the positional cloning era. His subsequent work on the APC gene transformed the landscape of colorectal cancer research, while his stewardship of BioBank Japan created the foundational infrastructure necessary for modern precision medicine.
ASHG Leadership Award: Dr. Aravinda Chakravarti
Dr. Chakravarti, of the NYU Grossman School of Medicine, is recognized for his role as a scientific architect. A central figure in the Human Genome Project, the International HapMap Project, and the 1000 Genomes Project, his influence on statistical genetics and complex disease modeling is immeasurable. His work on cystic fibrosis and Hirschsprung disease set the standard for how researchers bridge the gap between abstract genomic data and biological reality.
ASHG Scientific Achievement Award: Dr. Wendy Chung
Dr. Chung, Chief of Pediatrics at Boston Children’s Hospital, is honored for her transformative impact over the last decade. Her work has redefined the "diagnostic odyssey" for patients with rare diseases. By identifying over 60 disease-associated genes, she has successfully moved genomic discoveries from the laboratory bench to the patient’s bedside, establishing new protocols for newborn screening and therapeutic intervention.
ASHG Early Career Award: Dr. Rebecca Ahrens-Nicklas
Representing the future of the field, Dr. Ahrens-Nicklas of the Children’s Hospital of Philadelphia (CHOP) is recognized for her pioneering work in individualized genomic medicine. Her leadership in developing the world’s first personalized in vivo CRISPR therapy for an infant with a rare metabolic disease signals a new frontier where "incurable" conditions may soon be treatable through bespoke genetic interventions.
ASHG Advocacy Award: Roxanne Khamsi
Recognizing that scientific progress is meaningless without public understanding, the ASHG has awarded journalist Roxanne Khamsi for her two decades of reporting. Her work, spanning The Atlantic, WIRED, and The New York Times, bridges the gap between technical genomics and the public imagination. Her recent book, Beyond Inheritance, serves as a vital critique of how we conceptualize genetic "mutations," urging a more nuanced, compassionate, and accurate public discourse.
ASHG Education Award: Dr. Robbee Wedow
Dr. Wedow, an Assistant Professor at Purdue University, is honored for his work on the "Humane Genetics Curriculum" (HGC). In an era of increasing societal polarization, Dr. Wedow’s work provides educators with the tools to teach complex topics—such as race, ancestry, and genetic variation—with scientific precision and social responsibility.
ASHG Mentorship Award: Dr. Nancy B. Spinner
Dr. Spinner, Associate Chair of Genomic Strategy at Northwell Health, is lauded for a 35-year commitment to cultivating the next generation of scientists. Having trained dozens of laboratory directors who now lead institutions worldwide, her legacy is defined by her ability to recognize the unique potential in each mentee, fostering a culture of generosity and rigor in academic medicine.
Chronology of Impact: From Mapping to Curing
The development of the field of human genetics has been a rapid, non-linear progression. The 2026 awardees represent the various epochs of this development:
- 1980s – 1990s: The Mapping Era: Dr. Nakamura and Dr. Chakravarti were instrumental in this period, creating the markers and statistical frameworks that allowed scientists to locate genes associated with specific diseases.
- 2000s – 2010s: The Genomic Era: With the completion of the Human Genome Project, the focus shifted to large-scale data and population genetics. This period saw the rise of global initiatives like HapMap, where both Dr. Chakravarti and Dr. Nakamura played pivotal leadership roles.
- 2015 – 2026: The Precision and Translational Era: Recent years have seen the rise of personalized medicine. Dr. Chung and Dr. Ahrens-Nicklas embody this shift, focusing on the individual patient, rapid diagnostics, and bespoke therapies.
Official Responses and Institutional Vision
Susan A. Slaugenhaupt, PhD, President of the ASHG, emphasized that these awards are not merely accolades for past work, but indicators of the field’s future direction.
"ASHG is honored to recognize this exceptional group of awardees," Dr. Slaugenhaupt stated. "Each honoree has helped shape a stronger, more collaborative, and more impactful field. Their achievements inspire our community and reflect the promise of genetics to improve lives around the world. We are looking at a group of individuals who have not only asked the right questions but have built the institutions and frameworks necessary to find the answers."
The institutional impact of these awards is significant. By recognizing individuals like Roxanne Khamsi and Dr. Robbee Wedow, the ASHG is explicitly stating that the "science of genetics" now encompasses ethics, education, and public communication as core pillars of the discipline.
Implications for the Global Scientific Community
The 2026 awards highlight a critical pivot point in human genetics. The field is moving away from a "one-size-fits-all" approach to medicine and toward a future defined by three key pillars:
1. The Rise of Individualized Therapeutics
The recognition of Dr. Ahrens-Nicklas underscores that "personalized medicine" is no longer a buzzword; it is a clinical reality. The ability to design a CRISPR-based therapy for a single patient suggests that the cost and complexity barriers of gene therapy are being systematically dismantled.
2. The Integration of Sociology and Biology
The awarding of the Education prize to Dr. Wedow acknowledges that genetic data does not exist in a vacuum. As genomic technology becomes more accessible, the potential for misuse and misunderstanding grows. The ASHG is signaling that the field must prioritize the "social literacy" of genetics to ensure that research is used to empower, rather than stigmatize, diverse populations.
3. The Shift toward Global Infrastructure
The careers of Dr. Nakamura and Dr. Chakravarti demonstrate that the most significant breakthroughs are no longer the product of isolated "lone wolf" researchers. Instead, they are the result of massive, global infrastructures like BioBank Japan and the 1000 Genomes Project. The future of the field relies on continued international cooperation and the democratization of data access.
Conclusion
As the international community prepares for the ASHG 2026 Annual Meeting in Montréal, the focus remains clear: genetics is the most powerful tool available for understanding the human condition. By honoring these seven individuals, the ASHG is not only celebrating past brilliance but is providing a roadmap for the next generation of scientists.
The integration of clinical expertise, ethical journalism, and rigorous mentorship ensures that the field of human genetics will remain at the forefront of medical innovation for decades to come. Registration for the ASHG 2026 meeting is currently open, offering the global community a platform to engage with these leaders and the groundbreaking work they continue to champion.
About the Author
